PepGen (PEPG) Change in Account Payables (2021 - 2026)
PepGen (PEPG) posted Change in Account Payables of -$183000.0 for Q1 2026, down 608.33% sequentially from $36000.0 in Q4 2025, and down 119.41% YoY from $943000.0 in Q1 2025.
Powered by 
Analysis
PepGen (PEPG) Change in Account Payables (2021 - 2026) Analysis & Trends
PepGen has reported Change in Account Payables for 6 years, with the latest figure at -$183000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 119.41% year-over-year to -$183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 230.69% YoY) and the FY2025 annual result came in at -$935000.0, down 229.5% from the prior year.
- Change in Account Payables retreated to -$183000.0 in Q1 2026 per PEPG's latest filing, from $36000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $6.5 million in Q2 2024 and troughed at -$4.2 million in Q4 2024.
- A 5-year average of -$127764.7 and a median of -$86000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables slumped 3919.05% in 2022, then jumped 1440.76% in 2024.
- Over 5 years, Change in Account Payables stood at -$3.2 million in 2022, then increased by 9.46% to -$2.9 million in 2023, then slumped by 43.14% to -$4.2 million in 2024, then soared by 100.86% to $36000.0 in 2025, then tumbled by 608.33% to -$183000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$183000.0, $36000.0, and -$86000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 412,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 412,000.00 |
| Mar 31, 2026 | -183,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -1.83 Mn |
| Mar 31, 2025 | 943,000.00 |
| Dec 31, 2024 | -4.19 Mn |
| Sep 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 88,000.00 |
| Dec 31, 2023 | -2.93 Mn |
| Sep 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 422,000.00 |
| Mar 31, 2023 | -120,000.00 |
| Dec 31, 2022 | -3.24 Mn |
| Sep 30, 2022 | 395,000.00 |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | -1.60 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Sep 30, 2021 | -1.08 Mn |